Pernix Therapeutics Stock Price (NASDAQ:PTX)

Add to My Stocks
$2.45 $0 (0%) PTX stock closing price Jun 15, 2018 (Closing)
Prev Close* : $2.45
Market Cap:
Day Low: $2.4
52 Week Low: $2.00
Open: $2.43
Volume: -
Day High: $2.47
52 Week High: $5.18

Latest Stock Market News

Latest Articles

Pernix Therapeutics News - From Partners

Pernix Therapeutics Announces Sale of Non-Core Product   by Globe Newswire on Nov 06, 2017

PTX Stockcharts

View PTX PE ratio, PS ratio stocks charts and compare with peers.
PTX Chart
Note: Compare Pernix Therapeutics stock price history with the index and industry peers.

Pernix Therapeutics Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Pernix Therapeutics Returns

(return on equity)

Pernix Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

PTX Industry Peers

Company Price Change (%)
Versartis (VSAR)2.450.15 (6.52%)
Evoke Pharma (EVOK)2.710.05 (1.81%)
Cumberland Pharma (CPIX)6.010.01 (0.17%)
Vanda Pharmaceuticals (VNDA)18.750.45 (2.46%)
Depomed (DEPO)7.120.15 (2.15%)
Eli Lilly (LLY)86.880.53 (0.61%)
Durect (DRRX)2.20.09 (4.27%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Dr. Reddy's Laboratories (RDY)35.062.04 (6.18%)
Akorn (AKRX)15.420.38 (2.53%)
Aquinox Pharma (AQXP)15.290.35 (2.34%)
Supernus Pharma (SUPN)54.951.2 (2.23%)
Mallinckrodt (MNK)19.170.34 (1.81%)
Top gainers from Medical-Generic Drugs industry
* As of Jun 16, 2018
CompanyPriceChange (%)
Adamas Pharma (ADMS)26.121.35 (4.91%)
Progenics Pharma (PGNX)8.70.16 (1.81%)
Teligent (TLGT)3.560.05 (1.39%)
AxoGen (AXGN)49.50.65 (1.3%)
Mylan (MYL)390.51 (1.29%)
Allergan (AGN)173.180.77 (0.44%)
Corium (CORI)9.290.01 (0.11%)
Top losers from Medical-Generic Drugs industry
* As of Jun 16, 2018

Pernix Therapeutics Holdings Inc Stock News - Partner Headlines

Pernix Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues146.06M140.85M175.85M121.74M84.87M
Net Income-77.14M-169.59M-148.31M-35.28M-25.63M
Total Operating Expense157.1M237.84M225.68M106.78M95.64M
View Pernix Therapeutics income statement
balance sheet20172016201520142013
Total Assets205.49M310.44M511.15M487.41M211.38M
Total Liabilities379.74M424.5M478.06M403.82M100.66M
Shareholders Equity-174.25M-114.06M33.09M83.59M110.72M
View Pernix Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-3.5M22.73M-4.23M10.48M21.84M
Net Cash from (used by) Operating Activities-5.93M-16.5M-14.74M8.89M-6.53M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.98M-1.21M-1.13M19.09M
View Pernix Therapeutics cash flow statement

Pernix Therapeutics Stock Message Board

Pernix Therapeutics stock lost 0%, and the last close price as of Jun 15, 2018 is $2.45 for PTX stock. Stock price or share price can be used to find the total market value of a company. Pernix Therapeutics market cap stands at $29.09M as of Jun 15, 2018. Pernix Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Pernix Therapeutics is worth a lot, it will most likely be reflected in an inflated Pernix Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Pernix Therapeutics stock quote data shows the number of shares traded. For Ex: 24,473 Pernix Therapeutics shares were traded as of last trading day, as seen from Pernix Therapeutics stock chart. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Pernix Therapeutics does not pay dividends. Pernix Therapeutics stock price history, gives the entire historical data for PTX stock.